Global HIV and AIDS Clinical Trials Market Research Report 2023

HIV and AIDS clinical trials help researchers find better ways to prevent, detect, or treat HIV and AIDS. Examples of HIV and AIDS clinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV and AIDS.

The global HIV and AIDS Clinical Trials market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for HIV and AIDS Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of HIV and AIDS Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc. and Bionor Holding AS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for HIV and AIDS Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV and AIDS Clinical Trials.

The HIV and AIDS Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global HIV and AIDS Clinical Trials market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV and AIDS Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV and AIDS Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Phase I

1.2.3 Phase II

1.2.4 Phase III

1.2.5 Phase IV

1.3 Market by Application

1.3.1 Global HIV and AIDS Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Pharmaceutical & Biopharmaceutical Companies

1.3.3 Non Profit Organizations

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global HIV and AIDS Clinical Trials Market Perspective (2018-2029)

2.2 HIV and AIDS Clinical Trials Growth Trends by Region

2.2.1 Global HIV and AIDS Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 HIV and AIDS Clinical Trials Historic Market Size by Region (2018-2023)

2.2.3 HIV and AIDS Clinical Trials Forecasted Market Size by Region (2024-2029)

2.3 HIV and AIDS Clinical Trials Market Dynamics

2.3.1 HIV and AIDS Clinical Trials Industry Trends

2.3.2 HIV and AIDS Clinical Trials Market Drivers

2.3.3 HIV and AIDS Clinical Trials Market Challenges

2.3.4 HIV and AIDS Clinical Trials Market Restraints

3.1 Global Top HIV and AIDS Clinical Trials Players by Revenue

3.1.1 Global Top HIV and AIDS Clinical Trials Players by Revenue (2018-2023)

3.1.2 Global HIV and AIDS Clinical Trials Revenue Market Share by Players (2018-2023)

3.2 Global HIV and AIDS Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by HIV and AIDS Clinical Trials Revenue

3.4 Global HIV and AIDS Clinical Trials Market Concentration Ratio

3.4.1 Global HIV and AIDS Clinical Trials Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV and AIDS Clinical Trials Revenue in 2022

3.5 HIV and AIDS Clinical Trials Key Players Head office and Area Served

3.6 Key Players HIV and AIDS Clinical Trials Product Solution and Service

3.7 Date of Enter into HIV and AIDS Clinical Trials Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global HIV and AIDS Clinical Trials Historic Market Size by Type (2018-2023)

4.2 Global HIV and AIDS Clinical Trials Forecasted Market Size by Type (2024-2029)

5.1 Global HIV and AIDS Clinical Trials Historic Market Size by Application (2018-2023)

5.2 Global HIV and AIDS Clinical Trials Forecasted Market Size by Application (2024-2029)

6.1 North America HIV and AIDS Clinical Trials Market Size (2018-2029)

6.2 North America HIV and AIDS Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America HIV and AIDS Clinical Trials Market Size by Country (2018-2023)

6.4 North America HIV and AIDS Clinical Trials Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe HIV and AIDS Clinical Trials Market Size (2018-2029)

7.2 Europe HIV and AIDS Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe HIV and AIDS Clinical Trials Market Size by Country (2018-2023)

7.4 Europe HIV and AIDS Clinical Trials Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific HIV and AIDS Clinical Trials Market Size (2018-2029)

8.2 Asia-Pacific HIV and AIDS Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2018-2023)

8.4 Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America HIV and AIDS Clinical Trials Market Size (2018-2029)

9.2 Latin America HIV and AIDS Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America HIV and AIDS Clinical Trials Market Size by Country (2018-2023)

9.4 Latin America HIV and AIDS Clinical Trials Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa HIV and AIDS Clinical Trials Market Size (2018-2029)

10.2 Middle East & Africa HIV and AIDS Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2018-2023)

10.4 Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 PPD Inc.

11.1.1 PPD Inc. Company Detail

11.1.2 PPD Inc. Business Overview

11.1.3 PPD Inc. HIV and AIDS Clinical Trials Introduction

11.1.4 PPD Inc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.1.5 PPD Inc. Recent Development

11.2 IQVIA Inc.

11.2.1 IQVIA Inc. Company Detail

11.2.2 IQVIA Inc. Business Overview

11.2.3 IQVIA Inc. HIV and AIDS Clinical Trials Introduction

11.2.4 IQVIA Inc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.2.5 IQVIA Inc. Recent Development

11.3 Parexel International Corporation

11.3.1 Parexel International Corporation Company Detail

11.3.2 Parexel International Corporation Business Overview

11.3.3 Parexel International Corporation HIV and AIDS Clinical Trials Introduction

11.3.4 Parexel International Corporation Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.3.5 Parexel International Corporation Recent Development

11.4 ICON plc

11.4.1 ICON plc Company Detail

11.4.2 ICON plc Business Overview

11.4.3 ICON plc HIV and AIDS Clinical Trials Introduction

11.4.4 ICON plc Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.4.5 ICON plc Recent Development

11.5 Syneos Health

11.5.1 Syneos Health Company Detail

11.5.2 Syneos Health Business Overview

11.5.3 Syneos Health HIV and AIDS Clinical Trials Introduction

11.5.4 Syneos Health Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.5.5 Syneos Health Recent Development

11.6 WuXi AppTec

11.6.1 WuXi AppTec Company Detail

11.6.2 WuXi AppTec Business Overview

11.6.3 WuXi AppTec HIV and AIDS Clinical Trials Introduction

11.6.4 WuXi AppTec Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.6.5 WuXi AppTec Recent Development

11.7 Janssen Global Services, LLC

11.7.1 Janssen Global Services, LLC Company Detail

11.7.2 Janssen Global Services, LLC Business Overview

11.7.3 Janssen Global Services, LLC HIV and AIDS Clinical Trials Introduction

11.7.4 Janssen Global Services, LLC Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.7.5 Janssen Global Services, LLC Recent Development

11.8 Gilead Sciences, Inc.

11.8.1 Gilead Sciences, Inc. Company Detail

11.8.2 Gilead Sciences, Inc. Business Overview

11.8.3 Gilead Sciences, Inc. HIV and AIDS Clinical Trials Introduction

11.8.4 Gilead Sciences, Inc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.8.5 Gilead Sciences, Inc. Recent Development

11.9 Bionor Holding AS

11.9.1 Bionor Holding AS Company Detail

11.9.2 Bionor Holding AS Business Overview

11.9.3 Bionor Holding AS HIV and AIDS Clinical Trials Introduction

11.9.4 Bionor Holding AS Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.9.5 Bionor Holding AS Recent Development

11.10 Charles River Laboratories

11.10.1 Charles River Laboratories Company Detail

11.10.2 Charles River Laboratories Business Overview

11.10.3 Charles River Laboratories HIV and AIDS Clinical Trials Introduction

11.10.4 Charles River Laboratories Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.10.5 Charles River Laboratories Recent Development

11.11 GSK plc.

11.11.1 GSK plc. Company Detail

11.11.2 GSK plc. Business Overview

11.11.3 GSK plc. HIV and AIDS Clinical Trials Introduction

11.11.4 GSK plc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.11.5 GSK plc. Recent Development

11.12 SGS SA

11.12.1 SGS SA Company Detail

11.12.2 SGS SA Business Overview

11.12.3 SGS SA HIV and AIDS Clinical Trials Introduction

11.12.4 SGS SA Revenue in HIV and AIDS Clinical Trials Business (2018-2023)

11.12.5 SGS SA Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global HIV and AIDS Clinical Trials Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Phase I

    Table 3. Key Players of Phase II

    Table 4. Key Players of Phase III

    Table 5. Key Players of Phase IV

    Table 6. Global HIV and AIDS Clinical Trials Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global HIV and AIDS Clinical Trials Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global HIV and AIDS Clinical Trials Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global HIV and AIDS Clinical Trials Market Share by Region (2018-2023)

    Table 10. Global HIV and AIDS Clinical Trials Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global HIV and AIDS Clinical Trials Market Share by Region (2024-2029)

    Table 12. HIV and AIDS Clinical Trials Market Trends

    Table 13. HIV and AIDS Clinical Trials Market Drivers

    Table 14. HIV and AIDS Clinical Trials Market Challenges

    Table 15. HIV and AIDS Clinical Trials Market Restraints

    Table 16. Global HIV and AIDS Clinical Trials Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global HIV and AIDS Clinical Trials Market Share by Players (2018-2023)

    Table 18. Global Top HIV and AIDS Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Clinical Trials as of 2022)

    Table 19. Ranking of Global Top HIV and AIDS Clinical Trials Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by HIV and AIDS Clinical Trials Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players HIV and AIDS Clinical Trials Product Solution and Service

    Table 23. Date of Enter into HIV and AIDS Clinical Trials Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global HIV and AIDS Clinical Trials Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global HIV and AIDS Clinical Trials Revenue Market Share by Type (2018-2023)

    Table 27. Global HIV and AIDS Clinical Trials Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global HIV and AIDS Clinical Trials Revenue Market Share by Type (2024-2029)

    Table 29. Global HIV and AIDS Clinical Trials Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global HIV and AIDS Clinical Trials Revenue Market Share by Application (2018-2023)

    Table 31. Global HIV and AIDS Clinical Trials Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global HIV and AIDS Clinical Trials Revenue Market Share by Application (2024-2029)

    Table 33. North America HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America HIV and AIDS Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America HIV and AIDS Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe HIV and AIDS Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe HIV and AIDS Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific HIV and AIDS Clinical Trials Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America HIV and AIDS Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America HIV and AIDS Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 48. PPD Inc. Company Detail

    Table 49. PPD Inc. Business Overview

    Table 50. PPD Inc. HIV and AIDS Clinical Trials Product

    Table 51. PPD Inc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 52. PPD Inc. Recent Development

    Table 53. IQVIA Inc. Company Detail

    Table 54. IQVIA Inc. Business Overview

    Table 55. IQVIA Inc. HIV and AIDS Clinical Trials Product

    Table 56. IQVIA Inc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 57. IQVIA Inc. Recent Development

    Table 58. Parexel International Corporation Company Detail

    Table 59. Parexel International Corporation Business Overview

    Table 60. Parexel International Corporation HIV and AIDS Clinical Trials Product

    Table 61. Parexel International Corporation Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 62. Parexel International Corporation Recent Development

    Table 63. ICON plc Company Detail

    Table 64. ICON plc Business Overview

    Table 65. ICON plc HIV and AIDS Clinical Trials Product

    Table 66. ICON plc Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 67. ICON plc Recent Development

    Table 68. Syneos Health Company Detail

    Table 69. Syneos Health Business Overview

    Table 70. Syneos Health HIV and AIDS Clinical Trials Product

    Table 71. Syneos Health Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 72. Syneos Health Recent Development

    Table 73. WuXi AppTec Company Detail

    Table 74. WuXi AppTec Business Overview

    Table 75. WuXi AppTec HIV and AIDS Clinical Trials Product

    Table 76. WuXi AppTec Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 77. WuXi AppTec Recent Development

    Table 78. Janssen Global Services, LLC Company Detail

    Table 79. Janssen Global Services, LLC Business Overview

    Table 80. Janssen Global Services, LLC HIV and AIDS Clinical Trials Product

    Table 81. Janssen Global Services, LLC Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 82. Janssen Global Services, LLC Recent Development

    Table 83. Gilead Sciences, Inc. Company Detail

    Table 84. Gilead Sciences, Inc. Business Overview

    Table 85. Gilead Sciences, Inc. HIV and AIDS Clinical Trials Product

    Table 86. Gilead Sciences, Inc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 87. Gilead Sciences, Inc. Recent Development

    Table 88. Bionor Holding AS Company Detail

    Table 89. Bionor Holding AS Business Overview

    Table 90. Bionor Holding AS HIV and AIDS Clinical Trials Product

    Table 91. Bionor Holding AS Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 92. Bionor Holding AS Recent Development

    Table 93. Charles River Laboratories Company Detail

    Table 94. Charles River Laboratories Business Overview

    Table 95. Charles River Laboratories HIV and AIDS Clinical Trials Product

    Table 96. Charles River Laboratories Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 97. Charles River Laboratories Recent Development

    Table 98. GSK plc. Company Detail

    Table 99. GSK plc. Business Overview

    Table 100. GSK plc. HIV and AIDS Clinical Trials Product

    Table 101. GSK plc. Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 102. GSK plc. Recent Development

    Table 103. SGS SA Company Detail

    Table 104. SGS SA Business Overview

    Table 105. SGS SA HIV and AIDS Clinical Trials Product

    Table 106. SGS SA Revenue in HIV and AIDS Clinical Trials Business (2018-2023) & (US$ Million)

    Table 107. SGS SA Recent Development

    Table 108. Research Programs/Design for This Report

    Table 109. Key Data Information from Secondary Sources

    Table 110. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global HIV and AIDS Clinical Trials Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global HIV and AIDS Clinical Trials Market Share by Type: 2022 VS 2029

    Figure 3. Phase I Features

    Figure 4. Phase II Features

    Figure 5. Phase III Features

    Figure 6. Phase IV Features

    Figure 7. Global HIV and AIDS Clinical Trials Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global HIV and AIDS Clinical Trials Market Share by Application: 2022 VS 2029

    Figure 9. Pharmaceutical & Biopharmaceutical Companies Case Studies

    Figure 10. Non Profit Organizations Case Studies

    Figure 11. Others Case Studies

    Figure 12. HIV and AIDS Clinical Trials Report Years Considered

    Figure 13. Global HIV and AIDS Clinical Trials Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global HIV and AIDS Clinical Trials Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global HIV and AIDS Clinical Trials Market Share by Region: 2022 VS 2029

    Figure 16. Global HIV and AIDS Clinical Trials Market Share by Players in 2022

    Figure 17. Global Top HIV and AIDS Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Clinical Trials as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by HIV and AIDS Clinical Trials Revenue in 2022

    Figure 19. North America HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America HIV and AIDS Clinical Trials Market Share by Country (2018-2029)

    Figure 21. United States HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe HIV and AIDS Clinical Trials Market Share by Country (2018-2029)

    Figure 25. Germany HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific HIV and AIDS Clinical Trials Market Share by Region (2018-2029)

    Figure 33. China HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America HIV and AIDS Clinical Trials Market Share by Country (2018-2029)

    Figure 41. Mexico HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa HIV and AIDS Clinical Trials Market Share by Country (2018-2029)

    Figure 45. Turkey HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia HIV and AIDS Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. PPD Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 48. IQVIA Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 49. Parexel International Corporation Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 50. ICON plc Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 51. Syneos Health Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 52. WuXi AppTec Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 53. Janssen Global Services, LLC Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 54. Gilead Sciences, Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 55. Bionor Holding AS Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 56. Charles River Laboratories Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 57. GSK plc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 58. SGS SA Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed